At DrugVision.ai , we're committed to pushing the boundaries of organoid drug screening by integrating cutting-edge technologies into our...

In our recent webinar, we delved into the transformative potential of live-cell imaging for advancing organoid drug screening. A key...

This study embarked on an ambitious journey, utilizing twenty 384-well microplates, exploring 11 drug synergy combinations, and analyzing...

In this translational study, we explore pancreatic ductal adenocarcinoma (PDAC) and its inherent treatment resistance, emphasizing the...

In this publication, we introduce an innovative drug screening methodology using patient-derived tumor organoids. This paper focuses on...

In our original manuscript, we delve into the foundational work behind the development of the OrBITS label-free organoid detection...

Introduction Live-cell imaging techniques are emerging as an invaluable tool for drug development, offering unprecedented insights into...

Introduction: Preclinical models are the cornerstone of drug screening and development, playing a pivotal role in the advancement of...